Metabolism of Chamaechromone In Vitro with Human Liver Microsomes and Recombinant Human Drug-Metabolizing Enzymes

Abstract

Chamaechromone is a major component in the dried roots of Stellera chamaejasme with antihepatitis B virus and insecticidal activity. In this study, metabolic profiles of chamaechromone were investigated in human liver microsomes. One monohydroxide and two monoglucuronides of chamaechromone were identified. The enzyme kinetics for both hydroxylation and glucuronidation were fitted to the Michaelis–Menten equation. The hydroxylation of chamaechromone was inhibited by α-naphthoflavone, and predominantly catalyzed by recombinant human cytochrome P450 1A2, whereas the glucuronidation was inhibited by quercetin, 1-naphthol, and fluconazole, and mainly catalyzed by recombinant human UDP-glucuronosyltransferase 1A3, 1A7, 1A9, and 2B7.

Key words

Stellera chamaejasme - Thymelaeaceae - chamaechromone - metabolite - in vitro - human liver microsomes - recombinant human enzymes

• References

• 1 Chinese Pharmacopoeia Commission. Pharmacopoeia of China, Part 1. Beijing: Peopleʼs Health Press; 2010: 269
• 2 Asada Y, Sukemori A, Watanabe T, Malla KJ, Yoshikawa T, Li W, Koike K, Chen CH, Akiyama T, Qian K, Nakagawa-Goto K, Morris-Natschke SL, Lee KH. Stelleralides A–C, novel potent anti-HIV daphnane-type diterpenoids from Stellera chamaejasme L. Org Lett 2011; 13: 2904-2907
• 3 Yang GH, Chen DF. Biflavanones, flavonoids, and coumarins from the roots of Stellera chamaejasme and their antiviral effect on hepatitis B virus. Chem Biodivers 2008; 5: 1419-1424
• 4 Wang LP, Duan HY, Wang YS, Liu K, Jiang P, Qu Z, Yagasaki K, Zhang GY. Inhibitory effects of Lang-du extract on the in vitro and in vivo growth of melanoma cells and its molecular mechanisms of action. Cytotechnology 2010; 62: 357-366
• 5 Shi GL, Liu SQ, Cao H, Zhao LL, Li J, Li SY. Acaricidal activities of extracts of Stellera chamaejasme against Tetranychus viennensis (Acari: Tetranychidae). J Econ Entomol 2004; 97: 1912-1916
• 6 Xu ZH, Qin GW, Li XY, Xu RS. New biflavanones and bioactive compounds from Stellera chamaejasme L. Acta Pharm Sinica 2001; 36: 669-671
• 7 Tang XR, Hou TP. Isolation and identification of 2-isopropyl-5-methylphenol from Stellera chamaejasme and its insecticidal activity against Aphis craccivora and Pieris rapae . Nat Prod Res 2011; 25: 381-386
• 8 Wang YW, Zhang GZ, Xu HH, Zhao SH. Biological activity of extract of Stellera chamaejasme against five pest insects. Insect Sci 2002; 9: 17-22
• 9 Duan JA, Su SL, Fan XS, Qian DW, Tang YP, Shang EX, Guo JM, Liu P. Exploration of action patterns and mechanisms of Traditional Chinese Medicine incompatibility of Qi–Qing antagonism and mutual inhibition/restraint based on drug interaction. World Sci Technol 2012; 14: 1547-1552
• 10 Su XL, Lin RC, Wong SK, Tsui SK, Kwan SY. Identification and characterization of the Chinese herb Langdu by LC-MS/MS analysis. Phytochem Anal 2003; 14: 40-47
• 11 Wang W, Pan Q, Han XY, Wang J, Tan RQ, He F, Dou DQ, Kang TG. Simultaneous determination of arctiin and its metabolites in rat urine and feces by HPLC. Fitoterapia 2013; 86: 6-12
• 12 Lou Y, Hu HH, Liu Y, Yu QQ, Li L, Pin L, Yu LS, Jiang HD, Zeng S. Determination of chamaechromone in rat plasma by liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study. J Pharm Biomed Anal 2011; 55: 1163-1169
• 13 Lou Y, Zheng JQ, Wang BH, Zhang XG, Zhang X, Zeng S. Metabolites characterization of chamaechromone in vivo and in vitro by using ultra-performance liquid chromatography/Xevo G2 quadrupole time-of-flight tandem mass spectrometry. J Ethnopharmacol 2014; 151: 242-252
• 14 Martignoni M, Groothuis GM, de Kanter R. Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction. Expert Opin Drug Metab Toxicol 2006; 2: 875-894
• 15 Mohamed ME, Frye RF. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Med 2011; 77: 311-321
• 16 Sousa MC, Braga RC, Cintra BAS, Oliveira V, Andrade CH. In silico metabolism studies of dietary flavonoids by CYP1A2 and CYP2C9. Food Res Int 2013; 50: 102-110
• 17 Song WY, Ji HY, Baek NI, Jeong TS, Lee HS. In vitro metabolism of jaceosidin and characterization of cytochrome P450 and UDP-glucuronosyltransferase enzymes in human liver microsomes. Arch Pharm Res 2010; 33: 1985-1996
• 18 Kiang TK, Ensom MH, Chang TK. UDP-glucuronosyltransferase and clinical drug-drug interactions. Pharmacol Ther 2005; 106: 97-132
• 19 Miners JO, Mackenzie PI, Knight KM. The prediction of drug-glucuronidation parameters in humans: UDP-glucuronosyltransferase enzyme-selective substrate and inhibitor probes for reaction phenotyping and in vitro-in vivo extrapolation of drug clearance and drug-drug interaction potential. Drug Metab Rev 2010; 42: 189-201
• 20 Chen Y, Chen S, Li X, Wang X, Zeng S. Genetic variants of human UGT1A3: functional characterization and frequency distribution in a Chinese Han population. Drug Metab Dispos 2006; 34: 1462-1467
• 21 Niwa M, Liu GQ, Tatematsu H, Hirata Y. Chamaechromone, a novel rearranged biflavonoid from Stellera chamaejasme L. Tetrahedron Lett 1984; 25: 3735-3738
• 22 Zhang X, Yao Y, Lou Y, Jiang HD, Wang XW, Chai XJ, Zeng S. Metabolism of ebracteolata compound B studied in vitro with human liver microsomes, HepG2 Cells, and recombinant human enzymes. Drug Metab Dispos 2010; 38: 2157-2165
• 23 Zhang W, Kilicarslan T, Tyndale RF, Sellers EM. Evaluation of methoxsalen, tranylcypromine, and tryptamine as specific and selective CYP2A6 inhibitors in vitro . Drug Metab Dispos 2001; 29: 897-902
• 24 Dierks EA, Stams KR, Lim HK, Cornelius G, Zhang H, Ball SE. A method for the simultaneous evaluation of the activities of seven major human drug-metabolizing cytochrome P450 s using an in vitro cocktail of probe substrates and fast gradient liquid chromatography tandem mass spectrometry. Drug Metab Dispos 2001; 29: 23-29
• 25 Baldwin SJ, Bloomer JC, Smith GJ, Ayrton AD, Clarke SE, Chenery RJ. Ketoconazole and sulphaphenazole as the respective selective inhibitors of P450 3A and 2C9. Xenobiotica 1995; 25: 261-270
• 26 Ko JW, Desta Z, Soukhova NV, Tracy T, Flockhart DA. In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6. Br J Clin Pharmacol 2000; 49: 343-351
• 27 Hesse LM, Venkatakrishnan K, von Moltke LL, Shader RI, Greenblatt DJ. CYP3A4 is the major CYP isoform mediating the in vitro hydroxylation and demethylation of flunitrazepam. Drug Metab Dispos 2001; 29: 133-140
• 28 Aprile S, Del Grosso E, Grosa G. Identification of the human UDP-glucuronosyltransferases involved in the glucuronidation of combretastatin A-4. Drug Metab Dispos 2010; 38: 1141-1146
• 29 Di Marco A, DʼAntoni M, Attaccalite S, Carotenuto P, Laufer R. Determination of drug glucuronidation and UDP-glucuronosyltransferase selectivity using a 96-well radiometric assay. Drug Metab Dispos 2005; 33: 812-819
• 30 Liu HX, He YQ, Hu Y, Liu Y, Zhang JW, Li W, Wang ZT, Yang L. Determination of UDP-glucuronosyltransferase UGT2B7 activity in human liver microsomes by ultra-performance liquid chromatography with MS detection. J Chromatogr B Analyt Technol Biomed Life Sci 2008; 870: 84-90